Thyroid Cancer
New Findings Reported from Sichuan University Describe Advances in Thyroid Cancer
Published in Cancer Weekly, November 15th, 2011
2011 NOV 15 -- "The present study was conducted to investigate salivary iodine kinetics and dosimetry during repeated courses of radioiodine (I-131) therapy for differentiated thyroid cancer (DTC). Such data could provide a better understanding of the mechanisms of I-131 induced salivary toxicity and help to develop appropriate methods to reduce this injury," scientists in Chengdu, People's Republic of China report.
"Seventy-eight consecutive DTC patients (mean age 45 +/- 17 years, 60%, female) undergoing I-131 therapy for remnant ablation or metastatic tumors were prospectively recruited. Planar quantitative scintigraphy of head-neck images was serially...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2011-11-15)
More Articles from Cancer Weekly
- Pancreatic Cancer
Ashworth College to Participate in PurpleStride Atlanta - Lung Cancer
Baron & Budd, P.C. Supports National Lung Cancer Awareness Month - Lung Cancer
Biomoda Files New Patent Application To Optimize CyPath(R) Assay - Quality of Life
Cancer survivorship research must look at quality of life - Central Desktop
Central Desktop Supports THE Breast Cancer Fundraiser's Nationwide Efforts with Product Donation - Cancer Research
Data on Cancer Research Detailed by F. Caruso and Co-Authors - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
